Olaparib Monotherapy as Primary Treatment in Unselected Triple Negative Breast Cancer. Eikesdal HP, Yndestad S, Elzawahry A, Llop-Guevara A, et al. Ann Oncol 2020 Nov 23. pii: S0923-7534(20)43164.

Read + Share

Amedeo Smart

Independent Medical Education

Eikesdal HP, Yndestad S, Elzawahry A, Llop-Guevara A, et al. Olaparib Monotherapy as Primary Treatment in Unselected Triple Negative Breast Cancer. Ann Oncol 2020 Nov 23. pii: S0923-7534(20)43164.
PMID: 33242536